Skip to main content
logo
Chimeric Therapeutics Limited (ASX:CHM)
Australia flag Australia · Delayed Price · Currency is AUD
0.0430
+0.0030 (7.50%)
Aug 5, 2026, 4:10 PM AEST

Chimeric Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
9.7512.687.464.512.62-
Revenue Growth
-23.14%70.09%65.52%72.16%--
Gross Profit
8.911.847.464.512.62-
Operating Income
-5.31-6.49-12.31-24.98-14.57-14.85
Net Income
-18.79-10.43-12.53-25.92-15.9-15.11
Earnings Per Share
-0.76-0.77-1.80-5.98-4.42-8.31
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
2.55.763.052.3618.3822.41
Total Debt
------
Net Cash (Debt)
2.55.763.052.3618.3822.41
Net Cash Growth
-56.52%88.58%29.22%-87.15%-17.98%-
Net Cash Per Share
0.100.430.440.555.1112.32

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-8.49-7.28-7.54-16.31-13.15-8.83
Capital Expenditures
-----0.01-0.02
Free Cash Flow
-8.49-7.28-7.54-16.31-13.17-8.85
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
91.31%93.32%100.00%100.00%100.00%-
Operating Margin
-54.44%-51.14%-165.01%-554.44%-556.82%-
Pretax Margin
-192.54%-81.36%-167.88%-573.14%-601.22%-
Profit Margin
-192.71%-82.23%-168.01%-575.20%-607.48%-
FCF Margin
-87.11%-57.36%-101.07%-361.89%-503.04%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
0.230.642.354.2714.95-